Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Pilger, E.
space
  arrow  Doder, A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Thrombolytic Treatment and Balloon Angioplasty in Chronic Occlusion of the Aortic Bifurcation

right arrow Ernst Pilger, MD; Martin Decrinis, MD; Gerhard Stark, MD; Gunther Koch, MD; Andrea Obernosterer, MD; Robert Tischler, MD; Marianne Lafer, MD; and Alexander Doder, MD

1 January 1994 | Volume 120 Issue 1 | Pages 40-44

Objective: To evaluate nonsurgical alternatives in reopening chronically occluded aortic bifurcation.

Design: Uncontrolled randomized study.

Setting: University-affiliated referral center for vascular diseases.

Patients: Twenty-five of 39 consecutive patients with chronic aortoiliac disease including a totally occluded aortic bifurcation were found to be acceptable candidates for an aortobifemoral prosthetic graft.

Intervention: Patients were randomly assigned to receive either streptokinase or urokinase or recombinant tissue-type plasminogen activator (rt-PA). In cases of successful thrombolysis and residual obstructions, subsequent balloon angioplasty was attempted. Prosthetic bypass grafting was done if thrombolytic treatment and balloon angioplasty failed.

Results: Complete lysis was achieved in 5 of 25 patients (20%). In 10 (40%) patients, lysis showed residual obstructions, which were reopened mechanically in 8 patients; 2 patients had extra-anatomical bypass grafts. Ten patients (40%) without thrombolysis had surgical aortobifemoral bypass grafts. Overall, recanalization and clinical improvement were achieved in 13 of 25 patients (52%) by thrombolytic therapy and subsequent balloon angioplasty. The recanalization rate did not differ among the different thrombolytic drugs. However, rt-PA therapy resulted in reopening after 4 days of treatment; streptokinase, after 6 days; and urokinase, after 9 days (P < 0.005). No major complications or deaths occurred.

Conclusion: Thrombolytic treatment followed by balloon angioplasty may help avoid the need for aortobifemoral prosthetic bypass grafting in more than 50% of patients with chronic aortoiliac disease.

Author and Article Information
space

From Karl-Franzens-University, Graz, Austria.
Requests for Reprints: Ernst Pilger, MD, Division of Angiology, Department of Internal Medicine, Karl-Franzens-University, Auenbruggerplatz 15, A-8036 Graz, Austria.




This article has been cited by other articles:


Home page
JWatch GeneralHome page
THROMBOLYSIS AND ANGIOPLASTY FOR AORTOILIAC DISEASE
Journal Watch (General), January 14, 1994; 1994(114): 7 - 7.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1994 by the American College of Physicians.